# Phase I Pharmacokinetic Study (BF-BLOCK)

> **NCT01423305** · PHASE1 · COMPLETED · sponsor: **Orion Corporation, Orion Pharma** · enrollment: 20 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Budesonide/formoterol capsule.
- **DRUG:** Budesonide/formoterol capsule for oral adm.

## Key facts

- **NCT ID:** NCT01423305
- **Lead sponsor:** Orion Corporation, Orion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2011-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01423305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01423305, "Phase I Pharmacokinetic Study (BF-BLOCK)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01423305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*